Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective for symptom control.
Insights April 15, 2021
Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder
J Clin Psychiatry 2020;81(4):OT19046AH1
Vol 86 • 2025 • Number 3
Read the Current Issue
Original Research
Postpartum Distress in Women With and Without ADHD
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report
In Memoriam
In Memoriam: Terence A. Ketter, MD
Narrative Review
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
Original Research
